Evidence map›Paper›PMID 34275874›Full record

ArticleBMJ global health2021

Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe.

Linda Alinafe Sande, Katleho Matsimela, Lawrence Mwenge, Collin Mangenah, Augustine Talumba Choko, Marc d'Elbée, Mohammed Majam, Cyprian Mostert, Inonge Matamwandi, Euphemia Lindelwe Sibanda and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 9 countries.

Linda Alinafe SandeFaculty of Public Health and Policy, Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK linda.sande@lshtm.ac.uk.
Katleho MatsimelaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Health Economics and Epidemiology Research Office, Johannesburg, South Africa.
Lawrence MwengeHealth Economics Unit, Zambart, Lusaka, Zambia.
Collin MangenahCentre for Sexual Health, HIV/AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe.ORCID 0000-0002-0733-0622
Augustine Talumba ChokoPublic Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Marc d'ElbéeFaculty of Public Health and Policy, Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.
Mohammed MajamUniversity of the Witwatersrand, Ezintsha, Johannesburg, South Africa.
Cyprian MostertFaculty of Health Sciences, University of the Witwatersrand, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
Inonge MatamwandiHealth Economics Unit, Zambart, Lusaka, Zambia.
Euphemia Lindelwe SibandaCentre for Sexual Health and HIV/AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe.ORCID 0000-0003-1754-1076
Cheryl JohnsonHIV Department, WHO, Geneva, Switzerland.
Karin HatzoldPopulation Services International, Cape Town, South Africa.
Helen AylesZambart, Lusaka, Zambia.
Frances M CowanCentre for Sexual Health HIV/AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe.
Elizabeth Lucy CorbettDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Melissa NeumanMRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0002-8870-6504
Hendramoorthy MaheswaranImperial College London, London, UK.
Gesine Meyer-RathDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Health Economics and Epidemiology Research Office, Johannesburg, South Africa.
Fern Terris-PrestholtDepartment of Global Health & Development, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBUniversity of the Witwatersrand · ZACentre for Sexual Health and HIV AIDS Research · ZWInstitute of Health Economics · CAUniversity of Liverpool · GBBoston University · USImperial College London · GBJoint United Nations Programme on HIV/AIDS · CHLiverpool School of Tropical Medicine · GBWorld Health Organization · CHZambart · ZM

Funding

Medical Research Council MR/R010161/1Medical Research Council MR/S005307/1Wellcome TrustWellcome Trust WT091769World Health Organization 001
6 · The paper itself

Abstract

introductionAs countries approach the UNAIDS 95-95-95 targets, there is a need for innovative and cost-saving HIV testing approaches that can increase testing coverage in hard-to-reach populations. The HIV Self-Testing Africa-Initiative distributed HIV self-test (HIVST) kits using unincentivised HIV testing counsellors across 31 public facilities in Malawi, South Africa, Zambia and Zimbabwe. HIVST was distributed either through secondary (partner's use) distribution alone or primary (own use) and secondary distribution approaches.

methodsWe evaluated the costs of adding HIVST to existing HIV testing from the providers' perspective in the 31 public health facilities across the four countries between 2018 and 2019. We combined expenditure analysis and bottom-up costing approaches. We also carried out time-and-motion studies on the counsellors to estimate the human resource costs of introducing and demonstrating how to use HIVST for primary and secondary use.

resultsA total of 41 720 kits were distributed during the analysis period, ranging from 1254 in Zimbabwe to 27 678 in Zambia. The cost per kit distributed through the primary distribution approach was $4.27 in Zambia and $9.24 in Zimbabwe. The cost per kit distributed through the secondary distribution approach ranged from $6.46 in Zambia to $13.42 in South Africa, with a wider variation in the average cost at facility-level. From the time-and-motion observations, the counsellors spent between 20% and 44% of the observed workday on HIVST. Overall, personnel and test kit costs were the main cost drivers.

conclusionThe average costs of distributing HIVST kits were comparable across the four countries in our analysis despite wide cost variability within countries. We recommend context-specific exploration of potential efficiency gains from these facility-level cost variations and demand creation activities to ensure continued affordability at scale.

Indexed as

HIV InfectionsSelf-TestingHealth FacilitiesHumansMalawiMass ScreeningSouth AfricaZambiaZimbabweAIDSdiagnostics and toolshealth economicsHIVpublic health

Identifiers

PMID34275874
PMCPMC8287606
OpenAlexW3185822142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.